Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Was Rigel's $1.2B RA deal over-hyped?
Was Rigel's $1.2B RA deal over-hyped?
Was Rigel's $1.2B RA deal over-hyped?
Submitted by
admin
on February 22, 2010 - 3:30pm
Source:
Fierce Biotech
News Tags:
Rigel
partnerships
AstraZeneca
arthritis
Headline:
Was Rigel's $1.2B RA deal over-hyped?
Do Not Allow Advertisers to Use My Personal information
